Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence

This study has been completed.
Information provided by (Responsible Party):
Titan Pharmaceuticals Identifier:
First received: March 12, 2007
Last updated: October 18, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 5, 2011